Element Biosciences
The inclusion of institutional investors in the firm's recent $277 million Series D financing round positions it well for an IPO, should it choose that path.
Element Biosciences Raises $277M in Series D Funding
The company will use the money to further commercialize its benchtop DNA sequencer, Aviti, and to prepare for the launch of the Aviti24 multiomic profiling platform.
New Products Posted to GenomeWeb: Labcorp, Bio-Rad, Qiagen, Element Biosciences, Takara Bio, More
New products and services recently posted on GenomeWeb.
People in the News at Element Biosciences, CareDx, Nuclera, Genomtec
Recently posted executive and academic appointments, promotions, and departures in omics and molecular diagnostics.
At last week's AGBT meeting, the companies showcased new chemistries that turn their flow cells into stages for RNA, protein, and cellular analysis.
Nov 7, 2023
Aug 18, 2023
Jun 5, 2023
May 17, 2023
Mar 10, 2023